Oppenheimer Starts Ovid Therapeutics Inc (OVID) at Outperform, 'Imminent Pivotal Readouts'
Tweet Send to a Friend
(Updated - October 12, 2023 4:03 PM EDT)
Oppenheimer analyst Francois Brisebois initiates coverage on Ovid Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Francois Brisebois initiates coverage on Ovid Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
